Close×

Cardia Bioplastics has launched a sustainable bioproducts bag range which helps divert organic waste from landfill.

Cardia Bioproducts Compostable and Biohybrid Bags are now available for the use of retailers, councils, businesses and households.

The range includes compostable lunch bags, kitchen tidy bags, household waste bags, garden bags, nappy bags and dog waste bags.

A subsidiary of SECOS Group, Cardia was established in response to the strong global demand for finished sustainable packaging products. Mounting consumer pressure and changing legislation, such as plastic bag bans and global warming initiatives, continue to increase demand for compostable and biodegradable polymers.

Europe is the dominant market for compostable and biodegradable polymers, followed by North America, then Asia and Australia.

Currently, most households place organic material such as food scraps and garden waste into their co-mingled waste bin, adding up to a significant amount of material going into landfill that could be used elsewhere.

Cardia CEO Frank Glatz said the new range will compost fully within 12 weeks.

“Diverting organic waste from landfills using compostable waste management bags represents a large business opportunity for Cardia,” he said.

“Globally landfills are filling up, landfill costs are increasing and organic material can be utilised to create quality compost. The new bag range offers businesses and households the opportunity to make a quality sustainable choice.”

Food & Drink Business

Australia’s first social enterprise bakery, The Bread & Butter Project, has graduated its latest group of bakers, with its largest ever cohort marking the program’s 100th graduate.

The University of Sydney and Peking University have launched a Joint Centre for Food Security and Sustainable Agricultural Development, which will support research into improving the sustainability and security of food systems in Australia and China.

Sydney-based biotech company, All G, has secured regulatory approval in China to sell recombinant (made from microbes, not cows) lactoferrin. CEO Jan Pacas says All G is the first company in the world to receive the approval, and recombinant human lactoferrin is “next in line”.